
AstraZeneca to Acquire Caelum for ~500M
Shots: Alexion has exercised its option to acquire all remaining equity in Caelum for CAEL-101 which is currently being evaluated in P-III CARES clinical program […]
Shots: Alexion has exercised its option to acquire all remaining equity in Caelum for CAEL-101 which is currently being evaluated in P-III CARES clinical program […]
Copyright © 2022 | WordPress Theme by MH Themes